Capsida Biotherapeutics debuts with $ 140 million in capital

THOUSAND OAK, California, April 29, 2021 / PRNewswire / – Versant Ventures and Westlake Village BioPartners today announced the emergence of stealth mode from Capsida Biotherapeutics Inc., a biotechnology company using an adeno-associated virus (AAV) engineering and development platform of cargo to develop tissue-targeted gene therapies for several types of …

Read More »

Philippe Dro joins Adjuvant Capital as a partner

NEW YORK, April 29, 2021 / PRNewswire / – Adjuvant capital, a life sciences investment firm focused on global health, today announced that Phillipe dro, Pharm. D., MBA, will join as a partner and be based in Zurich, Switzerland. As an entrepreneur and seasoned executive in the field of biopharmacy …

Read More »